Roger W. Brimblecombe is Director at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have made 1 open-market trade across 1 company since 2006, most recently 2010-03-15.
CIK 0001197034
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRTX | 10,000 | $5.0M |
Shares reported on the most recent Form 4, priced at the 2010-03-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRTX | SELL · 10b5-1 | 2010-03-15 | 2010-03-16 | $43.10 | $431K | -21.7% | -0.1% | -0.1% |
| VRTX | SELL · 10b5-1 | 2008-05-27 | 2008-05-28 | $26.74 | $89K | -21.7% | -0.1% | -0.1% |
| VRTX | SELL · 10b5-1 | 2008-05-20 | 2008-05-21 | $27.60 | $92K | -21.7% | -0.1% | -0.1% |
| VRTX | SELL · 10b5-1 | 2008-05-13 | 2008-05-15 | $27.19 | $91K | -21.7% | -0.1% | -0.1% |
| VRTX | SELL · 10b5-1 | 2007-04-10 | 2007-04-11 | $32.36 | $324K | -21.7% | -0.1% | -0.1% |
| VRTX | SELL | 2006-02-13 | 2006-02-14 | $35.19 | $616K | -21.7% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.